查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1821632

2025年糖组学或糖生物学全球市场报告

Glycomics or Glycobiology Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

预计未来几年，糖组学（或糖生物学）市场规模将快速成长，到2029年将达到39.9亿美元，复合年增长率为17.0%。预测期内的增长可归因于以糖为核心的人工智慧 (AI) 和数据分析、基于糖生物学的药物开发的扩展、醣体学在疾病生物标记发现中的整合、个人化医疗以及基于糖的治疗方法。预测期内的主要趋势包括跨学科合作、疾病机制中的糖基化模式、创新的精准医疗和个人化治疗、糖分析工具的进步以及免疫疗法和疫苗中的糖。

未来五年17.0%的成长率预测较先前的预测略有下降，下降了0.2%。这一下降主要源自于美国与其他国家之间关税的影响。预计关税壁垒将阻碍美国，因为这将增加从德国和日本进口的聚醣分析仪和聚醣微阵列的成本，减缓慢性病生物标记的发现，并增加实验室支出。由于互惠关税以及日益加剧的贸易紧张局势和限制对全球经济和贸易的负面影响，其影响也将更加广泛。

治疗严重慢性疾病的药物需求激增，势必推动糖组学或糖生物学市场的成长。由于慢性疾病往往长期存在且无法治疗方法，因此需要进行广泛的醣质学研究，以了解糖基化变化及其在这些疾病药物开发中的功能意义。根据美国癌症协会发布的《2022-2024年癌症事实与数据》，预计到2040年，被归类为慢性疾病的癌症倖存者人数将从2032年的2250万增加到2600万。因此，治疗严重慢性疾病的药物需求不断增长，是糖组学或糖生物学市场的主要驱动力。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通膨、地缘政治、贸易战和关税，以及新冠疫情和復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球糖组学或糖生物学：PESTEL 分析（政治、社会、技术、环境、法律因素、驱动因素和限制因素）
  • 最终用途产业分析
  • 全球糖组学或糖生物学市场：增长率分析
  • 全球糖组学或糖生物学市场表现：规模与成长，2019-2024
  • 全球糖组学或糖生物学市场预测：规模与成长，2024-2029 年，2034 年预测
  • 全球糖组学或糖生物学：总潜在市场（TAM）

第六章 市场细分

  • 全球糖组学或糖生物学市场：按产品、实际情况和预测，2019-2024 年、2024-2029 年、2034 年
  • 酵素
  • 套件
  • 试剂和化学品
  • 装置
  • 碳水化合物
  • 全球糖组学或糖生物学市场：按应用、实际情况和预测，2019-2024 年、2024-2029 年、2034 年
  • 药物研发
  • 疾病诊断
  • 其他用途
  • 全球糖组学或糖生物学市场：按最终用户、实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 学术研究机构
  • 製药和生物技术公司
  • 临床实验室
  • 全球糖组学或糖生物学市场：按酵素类型、表现和预测细分，2019-2024 年、2024-2029 年、2034 年
  • 糖苷酶
  • 糖基转移酶
  • 唾液酸酶
  • 全球糖组学或糖生物学市场：细分试剂套件（按类型）、实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 聚醣分析套件
  • 糖生物研究套件
  • 全球糖组学或糖生物学市场：按试剂和化学品（按类型）细分，实际和预测，2019-2024 年、2024-2029 年、2034 年
  • 单醣
  • 寡糖
  • 化学改质剂
  • 全球糖组学或糖生物学市场：按设备类型细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 质谱仪
  • 层析法系统
  • 影像系统
  • 全球糖组学或糖生物学市场：按碳水化合物（按类型）细分，实际及预测，2019-2024 年、2024-2029 年、2034 年
  • 天然碳水化合物
  • 合成碳水化合物

第七章 区域和国家分析

  • 全球糖组学或糖生物学市场：按地区、实际结果和预测，2019-2024 年、2024-2029 年、2034 年
  • 全球糖组学或糖生物学市场：按国家/地区划分、实际结果和预测（2019-2024 年、2024-2029 年预测、2034 年预测）

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第18章：法国市场

第十九章：义大利市场

第20章：西班牙市场

第21章 东欧市场

第22章俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第30章：竞争格局与公司概况

  • 糖组学或糖生物学市场：竞争格局
  • 糖组学或糖生物学市场：公司简介
    • Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
    • New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Shimadzu Corporation
  • ProZyme Inc.
  • Takara Bio Inc.
  • Asparia Glycomics SL
  • Lectenz Bio
  • Chemily Glycoscience LLC
  • Z Biotech LLC
  • RayBiotech Inc.
  • Thermo Fisher Scientific Inc.
  • Promega Corporation
  • Bio-Techne Corp.
  • AMS Bio LLC
  • Ludger Ltd.
  • CD BioGlyco Ltd.
  • GlycoDiag SAS

第 32 章全球市场竞争基准化分析与仪表板

第33章 重大併购

第34章近期市场趋势

第 35 章：高潜力市场国家、细分市场与策略

  • 2029 年糖组学或糖生物学市场：提供新机会的国家
  • 2029 年糖组学或糖生物学市场：细分领域带来新机会
  • 糖组学或糖生物学市场 2029：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章 附录

简介目录
Product Code: r22647u

Glycomics or glycobiology encompasses the exploration of saccharides' structures, biosynthesis, and biological functions, delving into the intricate world of sugar chains or glycans widely present in natural systems. These glycans are thoroughly examined within the realm of glycobiology for their structural composition, production processes, and biological significance.

The primary products associated with glycomics or glycobiology include enzymes, kits, reagents and chemicals, instruments, and carbohydrates. Enzymes, as biological polymers, serve as catalysts for biochemical reactions. These products find application across various domains such as drug discovery and development, disease diagnostics, among others, and are extensively utilized within academic research institutes, pharmaceutical and biotechnology companies, as well as clinical laboratories.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The glycomics or glycobiology market research report is one of a series of new reports from The Business Research Company that provides glycomics or glycobiology market statistics, including glycomics or glycobiology industry global market size, regional shares, competitors with a glycomics or glycobiology market share, detailed glycomics or glycobiology market segments, market trends and opportunities, and any further data you may need to thrive in the glycomics or glycobiology industry. This glycomics or glycobiology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The glycomics or glycobiology market size has grown rapidly in recent years. It will grow from $1.85 billion in 2024 to $2.13 billion in 2025 at a compound annual growth rate (CAGR) of 14.9%. The growth in the historic period can be attributed to increased awareness of glycans in biological systems, expansion of glycan-related database and resources, rise in collaborative research initiatives, advancements in glycan synthesis and engineering, glycan biomarker identification.

The glycomics or glycobiology market size is expected to see rapid growth in the next few years. It will grow to $3.99 billion in 2029 at a compound annual growth rate (CAGR) of 17.0%. The growth in the forecast period can be attributed to glycan-focused artificial intelligence (AI) and data analytics, expansion in glycobiology-based drug development, integration of glycomics in disease biomarker discovery, personalized medicine, and glycan-based therapeutics. Major trends in the forecast period include cross-disciplinary collaborations, glycosylation patterns in disease mechanisms, innovative precision medicine and personalized therapies, advancements in glycoanalytical tools, glycans in immunotherapy and vaccines.

The forecast of 17.0% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff barriers are expected to hamper the U.S. by increasing the cost of glycan analyzers and carbohydrate microarrays sourced from Germany and Japan, thereby delaying biomarker discovery for chronic diseases and elevating research laboratory expenditures. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The surge in demand for medications catering to severe chronic diseases is poised to drive the growth of the glycomics or glycobiology market. Chronic diseases, which persist over the long term without definitive cures, prompt extensive research into glycomics to understand glycosylation changes and their functional implications in drug development for these conditions. According to the American Cancer Society's Cancer Facts and Figures 2022-2024, the number of cancer survivors, considered a chronic disease, is projected to increase from 22.5 million in 2032 to an estimated 26 million by 2040. Hence, the escalating demand for medications to treat severe chronic diseases acts as a significant driver for the glycomics or glycobiology market.

The rising need for pharmaceutical products is expected to be a major driver for the growth of the glycomics or glycobiology market. These products encompass drugs specifically formulated to diagnose, prevent, treat, or cure various medical conditions. Glycomics and glycobiology play crucial roles in pharmaceutical development by elucidating disease mechanisms, identifying therapeutic targets, and optimizing drug design and effectiveness. According to the European Federation of Pharmaceutical Industries and Associations (EFPIA), the total pharmaceutical production in Europe surged to $384,200 million (€340,000 million) in 2022, marking a significant 4.95% increase from the preceding year's $366,267 million (€323,950 million). Consequently, the heightened demand for pharmaceutical products acts as a catalyst propelling the glycomics or glycobiology market's growth.

A prevailing trend in the glycomics or glycobiology market is the emphasis on investments in research and development (R&D) endeavors. Prominent research institutions are channeling funding into glycobiology research centers, aiming to further advancements in glycomics or glycobiology. For instance, Griffith University's Institute for Glycomics unveiled the ACRF International center for Cancer Glycomics in August 2022. This pioneering facility, established with a $2.6 million ACRF grant, is dedicated to unraveling cancer glycocoding. It is envisioned as a unique resource, driving enhanced understanding of the glycocode and translating discoveries into clinical outcomes, ultimately improving the lives of cancer patients.

Leading companies within the glycomics or glycobiology market are innovating by developing cutting-edge products like glycan screening kits to cater to expanded customer bases and augment revenue streams. Glycan Screening Kits are specialized tools designed for comprehensive immunofluorescence detection of glycan expression in tissue sections, aiding researchers in characterizing complex glycans for insights into disease biomarkers and protein modifications. Vector Laboratories Inc., in July 2022, introduced its breakthrough product, the Glysite Scout Glycan Screening Kits. These fully integrated immunofluorescence kits offer robust capabilities for profiling glycan expression in tissue sections. The kits empower researchers to gain valuable insights into the significance of glycomics in samples, particularly in understanding post-translational protein modifications and disease biomarkers. With curated lectin selections, these kits enable the identification of major surface glycan motifs, enriching the understanding of disease progression, treatment impacts, and tissue characterization.

In October 2022, the Centre for Cellular and Molecular Platforms (C-CAMP), an India-based research foundation, entered into a partnership with Agilent Technologies, Inc. for an undisclosed amount. Through this collaboration, C-CAMP aims to enhance its portfolio by leveraging Agilent's expertise in mass spectrometry-based characterization of biotherapeutics and biosimilars. Agilent Technologies Inc., a US-based company, is known for offering AdvanceBio glycoenzymes.

Major companies operating in the glycomics or glycobiology market are Aligent Technologies Inc., Bruker Corporation, Merck Co. & KgaA, New England Biolabs Inc., Danaher Corporation, Shimadzu Corporation, ProZyme Inc., Takara Bio Inc., Asparia Glycomics SL, Lectenz Bio, Chemily Glycoscience LLC, Z Biotech LLC, RayBiotech Inc., Thermo Fisher Scientific Inc., Promega Corporation, Bio-Techne Corp., AMS Bio LLC, Ludger Ltd., CD BioGlyco Ltd., GlycoDiag SAS, Kode Biotech Limited, Glyxera GmBH, Glycomix Ltd., R&D Systems Inc.

North America was the largest region in the glycomics or glycobiology market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the glycomics or glycobiology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the glycomics or glycobiology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The glycomics or glycobiology market includes revenues earned by entities by maintaining tissue structure, porosity, and integrity. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Glycomics or Glycobiology Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on glycomics or glycobiology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for glycomics or glycobiology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The glycomics or glycobiology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product: Enzymes; Kits; Reagents And Chemicals; Instruments; Carbohydrates
  • 2) By Application: Drug Discovery And Development; Disease Diagnostics; Other Applications
  • 3) By End-User: Academic Research Institutes; Pharmaceutical And Biotechnology Companies; Clinical Laboratories
  • Subsegments:
  • 1) By Enzymes: Glycosidases; Glycosyltransferases; Sialidases
  • 2) By Kits: Glycan Analysis Kits; Glycobiology Research Kits
  • 3) By Reagents And Chemicals: Monosaccharides; Oligosaccharides; Chemical Modifiers
  • 4) By Instruments: Mass Spectrometers; Chromatography Systems; Imaging Systems
  • 5) By Carbohydrates: Natural Carbohydrates; Synthetic Carbohydrates
  • Companies Mentioned: Aligent Technologies Inc.; Bruker Corporation; Merck Co. & KgaA; New England Biolabs Inc.; Danaher Corporation; Shimadzu Corporation; ProZyme Inc.; Takara Bio Inc.; Asparia Glycomics SL; Lectenz Bio; Chemily Glycoscience LLC; Z Biotech LLC; RayBiotech Inc.; Thermo Fisher Scientific Inc.; Promega Corporation; Bio-Techne Corp.; AMS Bio LLC; Ludger Ltd.; CD BioGlyco Ltd.; GlycoDiag SAS; Kode Biotech Limited; Glyxera GmBH; Glycomix Ltd.; R&D Systems Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Glycomics or Glycobiology Market Characteristics

3. Glycomics or Glycobiology Market Trends And Strategies

4. Glycomics or Glycobiology Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Glycomics or Glycobiology Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Glycomics or Glycobiology PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Glycomics or Glycobiology Market Growth Rate Analysis
  • 5.4. Global Glycomics or Glycobiology Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Glycomics or Glycobiology Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Glycomics or Glycobiology Total Addressable Market (TAM)

6. Glycomics or Glycobiology Market Segmentation

  • 6.1. Global Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Enzymes
  • Kits
  • Reagents and Chemicals
  • Instruments
  • Carbohydrates
  • 6.2. Global Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Drug Discovery and Development
  • Disease Diagnostics
  • Other Applications
  • 6.3. Global Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Academic Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Clinical Laboratories
  • 6.4. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Enzymes, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glycosidases
  • Glycosyltransferases
  • Sialidases
  • 6.5. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Kits, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Glycan Analysis Kits
  • Glycobiology Research Kits
  • 6.6. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Reagents And Chemicals, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Monosaccharides
  • Oligosaccharides
  • Chemical Modifiers
  • 6.7. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mass Spectrometers
  • Chromatography Systems
  • Imaging Systems
  • 6.8. Global Glycomics or Glycobiology Market, Sub-Segmentation Of Carbohydrates, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Natural Carbohydrates
  • Synthetic Carbohydrates

7. Glycomics or Glycobiology Market Regional And Country Analysis

  • 7.1. Global Glycomics or Glycobiology Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Glycomics or Glycobiology Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Glycomics or Glycobiology Market

  • 8.1. Asia-Pacific Glycomics or Glycobiology Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Glycomics or Glycobiology Market

  • 9.1. China Glycomics or Glycobiology Market Overview
  • 9.2. China Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Glycomics or Glycobiology Market

  • 10.1. India Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Glycomics or Glycobiology Market

  • 11.1. Japan Glycomics or Glycobiology Market Overview
  • 11.2. Japan Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Glycomics or Glycobiology Market

  • 12.1. Australia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Glycomics or Glycobiology Market

  • 13.1. Indonesia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Glycomics or Glycobiology Market

  • 14.1. South Korea Glycomics or Glycobiology Market Overview
  • 14.2. South Korea Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Glycomics or Glycobiology Market

  • 15.1. Western Europe Glycomics or Glycobiology Market Overview
  • 15.2. Western Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Glycomics or Glycobiology Market

  • 16.1. UK Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Glycomics or Glycobiology Market

  • 17.1. Germany Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Glycomics or Glycobiology Market

  • 18.1. France Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Glycomics or Glycobiology Market

  • 19.1. Italy Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Glycomics or Glycobiology Market

  • 20.1. Spain Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Glycomics or Glycobiology Market

  • 21.1. Eastern Europe Glycomics or Glycobiology Market Overview
  • 21.2. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Glycomics or Glycobiology Market

  • 22.1. Russia Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Glycomics or Glycobiology Market

  • 23.1. North America Glycomics or Glycobiology Market Overview
  • 23.2. North America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Glycomics or Glycobiology Market

  • 24.1. USA Glycomics or Glycobiology Market Overview
  • 24.2. USA Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Glycomics or Glycobiology Market

  • 25.1. Canada Glycomics or Glycobiology Market Overview
  • 25.2. Canada Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Glycomics or Glycobiology Market

  • 26.1. South America Glycomics or Glycobiology Market Overview
  • 26.2. South America Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Glycomics or Glycobiology Market

  • 27.1. Brazil Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Glycomics or Glycobiology Market

  • 28.1. Middle East Glycomics or Glycobiology Market Overview
  • 28.2. Middle East Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Glycomics or Glycobiology Market

  • 29.1. Africa Glycomics or Glycobiology Market Overview
  • 29.2. Africa Glycomics or Glycobiology Market, Segmentation By Product, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Glycomics or Glycobiology Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Glycomics or Glycobiology Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Glycomics or Glycobiology Market Competitive Landscape And Company Profiles

  • 30.1. Glycomics or Glycobiology Market Competitive Landscape
  • 30.2. Glycomics or Glycobiology Market Company Profiles
    • 30.2.1. Aligent Technologies Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Bruker Corporation Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Merck Co. & KgaA Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. New England Biolabs Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Danaher Corporation Overview, Products and Services, Strategy and Financial Analysis

31. Glycomics or Glycobiology Market Other Major And Innovative Companies

  • 31.1. Shimadzu Corporation
  • 31.2. ProZyme Inc.
  • 31.3. Takara Bio Inc.
  • 31.4. Asparia Glycomics SL
  • 31.5. Lectenz Bio
  • 31.6. Chemily Glycoscience LLC
  • 31.7. Z Biotech LLC
  • 31.8. RayBiotech Inc.
  • 31.9. Thermo Fisher Scientific Inc.
  • 31.10. Promega Corporation
  • 31.11. Bio-Techne Corp.
  • 31.12. AMS Bio LLC
  • 31.13. Ludger Ltd.
  • 31.14. CD BioGlyco Ltd.
  • 31.15. GlycoDiag SAS

32. Global Glycomics or Glycobiology Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Glycomics or Glycobiology Market

34. Recent Developments In The Glycomics or Glycobiology Market

35. Glycomics or Glycobiology Market High Potential Countries, Segments and Strategies

  • 35.1 Glycomics or Glycobiology Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Glycomics or Glycobiology Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Glycomics or Glycobiology Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer